Circulating CD36+ microparticles are not altered by docosahexaenoic or eicosapentaenoic acid supplementation

- Phang, M., Thorne, R. F., Alkhatatbeh, M. J., Garg, M. L., Lincz, L. F.

The origin of circulating CD36 in type 2 diabetes

- Alkhatatbeh, M. J., Enjeti, A. K., Acharya, S., Thorne, R. F., Lincz, L. F.

The putative diabetic plasma marker, soluble CD36, is non-cleaved, non-soluble and entirely associated with microparticles

- Alkhatatbeh, M. J., Mhaidat, N. M., Enjeti, A. K., Lincz, L. F., Thorne, R. F.